The American Academy of Neurology (AAN) Annual Meeting will begin April 21 in Los Angeles, CA. The following NeuroNEXT events and presentations will take place:
- NeuroNEXT Meet & Greet Social: Please join us for a NeuroNEXT Meet & Greet on Monday, April 23 from 6:30-8pm PT at the O Hotel, 819 S. Flower St., Los Angeles. Light appetizers will be served and all Network affiliates are welcome.
- NN102 SPRINT-MS Plenary Presentation: Dr. Robert Fox will be presenting his project ("A Phase II Trial of Ibudilast in Progressive Multiple Sclerosis") on Tuesday, April 24, as part of the Clinical Trials Plenary Session that commences at 9:15am PT. Dr. Fox is expected to be presenting around 10:30am PT.
- NN103 Beat MG Abstract: Dr. Richard Nowak will present his NN103 Beat MG study abstract as part of the AAN Annual Meeting Emerging Science program. Titled "B Cell Targeted Treatment in Myasthenia Gravis (BeatMG) - A Phase 2 Trial of Rituximab in MG: Topline Results," the poster #P4.478 will be at Poster Session IV on Wednesdsay, April 25 from 11:30am-7pm PT and the in-person presentation will be from 5:30-7pm PT.
Please visit the AAN Annual Meeting site for more information on the plenary sessions or emerging science program.